Peak ProcessingASX:PKP Days Payable is 698.35 as of Dec. 2025, which is 224% above its 10-year median of 215.38. The stock has 7 warning signs investors should review. Among 920 Drug Manufacturers companies, Peak Processing ranks better than 96.09% on this metric.
The historical rank and industry rank for Peak Processing's Days Payable or its related term are showing as below:
ASX:PKP'
s Days Payable Range Over the Past 10 Years
Min: 146.15 Med: 215.38 Max: 942.92
Current: 774.33
During the past 7 years, Peak Processing's highest Days Payable was 942.92. The lowest was 146.15. And the median was 215.38.
ASX:PKP's Days Payable is ranked better than 96.09% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs ASX:PKP: 774.33
Peak Processing's Days Payable
increased
from Dec. 2024 (413.78) to Dec. 2025 (698.35).
It may suggest that Peak Processingdelayed paying its suppliers.
Peak Processing Days Payable Related Terms
Peak Processing Days Payable Historical Data
* Premium members only.
The historical data trend for Peak Processing's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Peak Processing's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Peak Processing Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Peak Processing's Days Payable distribution charts can be found below:
* The bar in red indicates where Peak Processing's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Peak Processing's Days Payable for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Peak Processing (ASX:PKP) has a Days Payable of 698.35 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Peak Processing and its competitors. This is 224% above median its historical median of 215.38. Over the past decade, Peak Processing's Days Payable has ranged from 146.15 to 942.92. According to the industry distribution chart, Peak Processing ranks #36 out of 920 companies in the Drug Manufacturers industry, placing it in the top 3.9%.
Is Peak Processing's Days Payable too high?
Peak Processing's current Days Payable of 698.35 is 224% above median its 10-year median of 215.38. Over the past 10 years, this metric has ranged from a low of 146.15 to a high of 942.92. The Drug Manufacturers industry median Days Payable is 90.84. Peak Processing's value of 698.35 is 668.8% above this industry median. Based on the distribution chart, Peak Processing ranks #36 out of 920 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Peak Processing's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peak Processing ranks #36 out of 920 companies for Days Payable. This places Peak Processing in the top 4% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.84. Peak Processing's value of 698.35 is 668.8% above this benchmark. Historically, Peak Processing's own Days Payable has ranged from 146.15 to 942.92 over the past decade. While the company's 10-year median is 215.38 vs. the industry median of 90.84, Peak Processing has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peak Processing's current Days Payable of 698.35 is 668.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Peak Processing and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peak Processing's current Days Payable is 698.35, which is 224% above median its own 10-year median of 215.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peak Processing stock overvalued right now?
Based on GuruFocus' analysis, Peak Processing (ASX:PKP) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current Days Payable is 698.35, which is 224% above median its 10-year median of 215.38 and 668.8% above the Drug Manufacturers industry median of 90.84. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Peak Processing (ASX:PKP), the current Days Payable is 698.35 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Peak Processing Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. The products of the company includes cannabis-infused beverage, Hydrocarbon Extracts, oils, vapes, topicals, powder, infused flowers, and others. The company is also engaged in manufacturing services for cannabis products and blending and mixing, bulk filling, packaging, labelling and lab testing work.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PKP has been successfully added to your 